Mark Beaudet - Net Worth and Insider Trading

Mark Beaudet Net Worth

The estimated net worth of Mark Beaudet is at least $796,396 dollars as of 2024-06-20. Mark Beaudet is the Director of Cipher Pharmaceuticals Inc and owns about 94,922 shares of Cipher Pharmaceuticals Inc (TSX:CPH) stock worth over $796,396. Details can be seen in Mark Beaudet's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Beaudet has not made any transactions after 2019-04-01 and currently still holds the listed stock(s).

Transaction Summary of Mark Beaudet

To

Mark Beaudet Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Beaudet owns 1 companies in total, including Cipher Pharmaceuticals Inc (TSX:CPH) .

Click here to see the complete history of Mark Beaudet’s form 4 insider trades.

Insider Ownership Summary of Mark Beaudet

Ticker Comapny Transaction Date Type of Owner
TSX:CPH Cipher Pharmaceuticals Inc 2019-04-01 Director

Mark Beaudet Latest Holdings Summary

Mark Beaudet currently owns a total of 1 stock. Mark Beaudet owns 94,922 shares of Cipher Pharmaceuticals Inc (TSX:CPH) as of April 1, 2019, with a value of $796,396.

Latest Holdings of Mark Beaudet

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:CPH Cipher Pharmaceuticals Inc 2019-04-01 94,922 8.39 796,396

Holding Weightings of Mark Beaudet


Mark Beaudet Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Beaudet has made a total of 0 transactions in Cipher Pharmaceuticals Inc (TSX:CPH) over the past 5 years. The most-recent trade in Cipher Pharmaceuticals Inc is the sale of 738 shares on April 1, 2019, which brought Mark Beaudet around $1,077.

Insider Trading History of Mark Beaudet

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Beaudet Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Beaudet Ownership Network

Ownership Network List of Mark Beaudet

No Data

Ownership Network Relation of Mark Beaudet

Insider Network Chart

Mark Beaudet Owned Company Details

What does Cipher Pharmaceuticals Inc do?

Who are the key executives at Cipher Pharmaceuticals Inc?

Mark Beaudet is the Director of Cipher Pharmaceuticals Inc. Other key executives at Cipher Pharmaceuticals Inc include Senior Officer Bryan Jacobs , Senior Officer Scott Langille , and Senior Officer Nadine Jutlah .

Cipher Pharmaceuticals Inc (TSX:CPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cipher Pharmaceuticals Inc (TSX:CPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cipher Pharmaceuticals Inc (TSX:CPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cipher Pharmaceuticals Inc (TSX:CPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cipher Pharmaceuticals Inc Insider Transactions

No Available Data

Mark Beaudet Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Beaudet. Currently GuruFocus does not have mailing address information for Mark Beaudet.

Discussions on Mark Beaudet

No discussions yet.